Israel-based Keystone Heart raises $14M for cerebral protection

Keystone Heart plans to pursue further clinical studies and boost commercialization with the $14 million it just added to its coffers.

Israeli device maker Keystone Heart raised $14 million in a Series B funding round in support of its TriGaurd implant, designed to help protect the brain during transcatheter valve replacement procedures.

Keystone Heart, OrbiMed

News Well, Funding Roundup, Implants, Minimally Invasive Surgery, Replacement Heart Valves, Stroke

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/RP8OIU